NSE:GLAXO
GlaxoSmithKline Pharmaceuticals Limited
- Stock
Last Close
2,964.60
02/05 08:51
Market Cap
431.92B
Beta: 0.09
Volume Today
152.98K
Avg: 51.02K
PE Ratio
64.03
PFCF: 16,370.88
Dividend Yield
1.31%
Payout:0%
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 3.81B - | 5.77B 51.35% | 4.65B 19.31% | 5.22B 12.18% | 6.54B 25.24% | 6.47B 1.03% | 7.23B 11.72% | 24.76B 242.37% | 8.41B 66.01% | 5.90B 29.89% | |
depreciation and amortization | 202.82M - | 247.76M 22.16% | 263.47M 6.34% | 379.86M 44.18% | 485.91M 27.92% | 826.78M 70.15% | 792.84M 4.11% | 681.86M 14.00% | 657.70M 3.54% | 695.36M 5.73% | |
deferred income tax | -77.46M - | -132.12M 70.57% | -128.51M 2.73% | -65.45M 49.07% | -25.33M 61.29% | ||||||
stock based compensation | 77.46M - | 132.12M 70.57% | 128.51M 2.73% | 65.45M 49.07% | 25.33M 61.29% | ||||||
change in working capital | -260.30M - | -1.24B 374.96% | -257.89M 79.14% | 1.65B 738.09% | -41.93M 102.55% | 440.68M 1,151.09% | 457.60M 3.84% | 1.20B 161.96% | -457.40M 138.16% | 610.21M 233.41% | |
accounts receivables | -31.40M - | 268.92M - | -497K 100.18% | -999.34M 200,974.85% | 102.04M 110.21% | 202.28M 98.24% | -302.69M 249.64% | ||||
inventory | -228.90M - | -1.50B 556.54% | 1.00B 166.59% | -743.86M 174.33% | 136.90M 118.40% | -677.17M 594.65% | -467.93M 30.90% | 120.03M 125.65% | 747.20M 522.53% | -650.78M 187.10% | |
accounts payables | -1.00B - | -482.30M 51.79% | 1.07B 322.70% | 1.02B 4.69% | -1.53B 249.66% | 1.90B 224.10% | |||||
other working capital | 266.51M - | -1.26B 572.25% | 2.39B 289.85% | 552.66M 76.87% | 1.60B 189.62% | 850.78M 46.85% | -47.10M 105.54% | 125.27M 365.97% | -337.69M 369.58% | ||
other non cash items | -1.05B - | -3.39B 221.86% | -2.30B 32.11% | -2.52B 9.52% | -2.99B 18.69% | -2.83B 5.18% | -2.70B 4.68% | -18.53B 585.74% | -3.77B 79.64% | -10.12M 99.73% | |
net cash provided by operating activities | 2.70B - | 1.39B 48.47% | 2.36B 69.55% | 4.73B 100.34% | 3.99B 15.53% | 4.90B 22.82% | 5.78B 17.82% | 8.11B 40.29% | 4.84B 40.27% | 6.75B 39.44% | |
investments in property plant and equipment | -1.30B - | -2.32B 78.03% | -3.04B 31.04% | -4.03B 32.51% | -2.91B 27.79% | -1.56B 46.48% | -442.27M 71.63% | -346.41M 21.67% | -440.40M 27.13% | -312.21M 29.11% | |
acquisitions net | 1.32B - | 4.03B 205.93% | 2.91B 27.79% | 1.56B 46.48% | 1.80B 15.46% | 335.20M 81.38% | 1.94B 479.39% | 44.69M 97.70% | |||
purchases of investments | -19.93B - | -7.87B 60.54% | -10.69B 35.92% | -12.41B 16.09% | -11.41B 8.06% | -33.78B 196.08% | -30.69B 9.14% | -52.64B 71.51% | -58.02B 10.22% | ||
sales maturities of investments | 25.60B - | 12.58B 50.85% | 7.37B 41.45% | 12.61B 71.22% | 12.33B 2.22% | 36.03B 192.23% | 12.57B 65.11% | 62.21B 394.88% | 56.79B 8.71% | ||
other investing activites | 2.75B - | 1.66B 39.36% | 18.78M 98.87% | 2.28B 12,057.04% | -1.63B 171.55% | -1.49B 8.88% | 578.18M 138.85% | 14.08B 2,335.20% | -2.99B 121.21% | 654.82M 121.93% | |
net cash used for investing activites | 1.44B - | 5.01B 247.83% | 3.01B 39.95% | -1.04B 134.64% | -1.43B 37.58% | -568.43M 60.34% | 4.19B 836.40% | -4.06B 196.87% | 8.08B 299.22% | -847.21M 110.49% | |
debt repayment | -7.42M - | -7.78M 4.78% | -6.06M 22.11% | -4.06M 33.00% | -4.06M 0% | -1.53M 62.32% | -240K 84.31% | -181.30M - | |||
common stock issued | |||||||||||
common stock repurchased | |||||||||||
dividends paid | -3.39B - | -5.29B 56.25% | -4.24B 20.00% | -2.54B 40.00% | -2.96B 16.67% | -3.39B 14.29% | -6.78B 100.00% | -5.07B 25.23% | -15.26B 201.10% | -5.42B 64.50% | |
other financing activites | -587.78M - | -1.08B 84.07% | -864.69M 20.08% | -519.20M 39.96% | -614.93M 18.44% | -884.03M 43.76% | -183.62M 79.23% | -175.83M 4.24% | -178.30M 1.40% | -17.90M 89.96% | |
net cash used provided by financing activities | -3.98B - | -6.38B 60.55% | -5.11B 19.98% | -3.07B 39.97% | -3.58B 16.87% | -4.28B 19.33% | -6.96B 62.79% | -5.24B 24.69% | -15.43B 194.39% | -5.61B 63.63% | |
effect of forex changes on cash | |||||||||||
net change in cash | 165.31M - | 17.59M 89.36% | 260.37M 1,380.54% | 619.71M 138.01% | -1.02B 265.12% | 60.35M 105.90% | 3.00B 4,877.34% | -1.19B 139.62% | -2.51B 111.13% | 310.38M 112.35% | |
cash at beginning of period | 1.16B - | 1.15B 0.61% | 1.39B 21.10% | 2.01B 44.54% | 987.77M 50.88% | 1.05B 6.11% | 4.05B 286.59% | 2.86B 29.37% | 550.38M 80.77% | ||
cash at end of period | 165.31M - | 1.17B 609.91% | 1.41B 20.08% | 2.01B 42.70% | 987.77M 50.88% | 1.05B 6.11% | 4.05B 286.59% | 2.86B 29.37% | 349.40M 87.79% | 860.76M 146.35% | |
operating cash flow | 2.70B - | 1.39B 48.47% | 2.36B 69.55% | 4.73B 100.34% | 3.99B 15.53% | 4.90B 22.82% | 5.78B 17.82% | 8.11B 40.29% | 4.84B 40.27% | 6.75B 39.44% | |
capital expenditure | -1.30B - | -2.32B 78.03% | -3.04B 31.04% | -4.03B 32.51% | -2.91B 27.79% | -1.56B 46.48% | -442.27M 71.63% | -346.41M 21.67% | -440.40M 27.13% | -312.21M 29.11% | |
free cash flow | 1.40B - | -931.30M 166.70% | -684.33M 26.52% | 694.13M 201.43% | 1.08B 55.73% | 3.35B 209.54% | 5.34B 59.50% | 7.76B 45.42% | 4.40B 43.28% | 6.44B 46.30% |
All numbers in INR (except ratios and percentages)